Matthew Emmens, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 10,850 shares at $41.76 ($453K) on 2012-11-16, disclosed to the SEC on 2012-11-20.
Open-market sale of $453k VRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |